124 related articles for article (PubMed ID: 16052216)
1. Positive thyroid transcription factor 1 staining strongly correlates with survival of patients with adenocarcinoma of the lung.
Barlési F; Pinot D; Legoffic A; Doddoli C; Chetaille B; Torre JP; Astoul P
Br J Cancer; 2005 Aug; 93(4):450-2. PubMed ID: 16052216
[TBL] [Abstract][Full Text] [Related]
2. Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma.
Anagnostou VK; Syrigos KN; Bepler G; Homer RJ; Rimm DL
J Clin Oncol; 2009 Jan; 27(2):271-8. PubMed ID: 19064983
[TBL] [Abstract][Full Text] [Related]
3. TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.
Perner S; Wagner PL; Soltermann A; LaFargue C; Tischler V; Weir BA; Weder W; Meyerson M; Giordano TJ; Moch H; Rubin MA
J Pathol; 2009 Jan; 217(1):65-72. PubMed ID: 18932182
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
[TBL] [Abstract][Full Text] [Related]
5. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
Skov BG; Fischer BM; Pappot H
Lung Cancer; 2008 Jan; 59(1):88-94. PubMed ID: 17905466
[TBL] [Abstract][Full Text] [Related]
6. Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas.
Siami K; McCluggage WG; Ordonez NG; Euscher ED; Malpica A; Sneige N; Silva EG; Deavers MT
Am J Surg Pathol; 2007 Nov; 31(11):1759-63. PubMed ID: 18059234
[TBL] [Abstract][Full Text] [Related]
7. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.
Wagner PL; Hyjek E; Vazquez MF; Meherally D; Liu YF; Chadwick PA; Rengifo T; Sica GL; Port JL; Lee PC; Paul S; Altorki NK; Saqi A
J Thorac Cardiovasc Surg; 2009 Mar; 137(3):615-21. PubMed ID: 19258077
[TBL] [Abstract][Full Text] [Related]
8. Is TTF1 a good immunohistochemical marker to distinguish primary from metastatic lung adenocarcinomas?
Reis-Filho JS; Carrilho C; Valenti C; Leitão D; Ribeiro CA; Ribeiro SG; Schmitt FC
Pathol Res Pract; 2000; 196(12):835-40. PubMed ID: 11156325
[TBL] [Abstract][Full Text] [Related]
9. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.
Liu L; Cohen C; Siddiqui MT
Acta Cytol; 2012; 56(4):425-30. PubMed ID: 22846220
[TBL] [Abstract][Full Text] [Related]
10. The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas.
Stoll LM; Johnson MW; Gabrielson E; Askin F; Clark DP; Li QK
Cancer Cytopathol; 2010 Dec; 118(6):441-9. PubMed ID: 20830690
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma.
Martins SJ; Takagaki TY; Silva AG; Gallo CP; Silva FB; Capelozzi VL
Lung Cancer; 2009 Apr; 64(1):105-9. PubMed ID: 18801593
[TBL] [Abstract][Full Text] [Related]
12. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
Zhu W; Michael CW
Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
[TBL] [Abstract][Full Text] [Related]
13. Thyroid transcription factor-1 amplification and expressions in lung adenocarcinoma tissues and pleural effusions predict patient survival and prognosis.
Li X; Wan L; Shen H; Geng J; Nie J; Wang G; Jia N; Dai M; Bai X
J Thorac Oncol; 2012 Jan; 7(1):76-84. PubMed ID: 22011671
[TBL] [Abstract][Full Text] [Related]
14. Gene expression signature predicts recurrence in lung adenocarcinoma.
Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
[TBL] [Abstract][Full Text] [Related]
15. Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma.
Yamashita S; Chujo M; Tokuishi K; Anami K; Miyawaki M; Yamamoto S; Kawahara K
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1303-8. PubMed ID: 19818968
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
17. STAT3 expression in gastric cancer indicates a poor prognosis.
Kim DY; Cha ST; Ahn DH; Kang HY; Kwon CI; Ko KH; Hwang SG; Park PW; Rim KS; Hong SP
J Gastroenterol Hepatol; 2009 Apr; 24(4):646-51. PubMed ID: 19175826
[TBL] [Abstract][Full Text] [Related]
18. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T
Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary intestinal-type adenocarcinoma.
Maeda R; Isowa N; Onuma H; Miura H
Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):349-51. PubMed ID: 18184677
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma.
Narahashi T; Niki T; Wang T; Goto A; Matsubara D; Funata N; Fukayama M
Histopathology; 2006 Oct; 49(4):349-57. PubMed ID: 16978197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]